The DOI matches its Crossref record; 90 of the 90 references it cites were found in a registry or an index.
Structural principles of tumor necrosis factor superfamily signaling
Abstract
Insights into the resting and active state structures of TNF superfamily receptors reveal opportunities for drug development.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The TNF and TNF Receptor Superfamilies
Locksley, R. M., Killeen, N., & Lenardo, M. J. (2001) · Cell · doi:10.1016/s0092-8674(01)00237-9 · Cited by 3,650
Signalling pathways of the TNF superfamily: a double-edged sword
Aggarwal, B. B. (2003) · Nature Reviews Immunology · doi:10.1038/nri1184 · Cited by 2,793
Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo.
Walczak, H., Miller, R. E., Ariail, K., Gliniak, B., Griffith, T. S., Kubin, M., Chin, W., Jones, J., Woodward, A., Le, T., et al. (1999) · Nature Medicine · doi:10.1038/5517 · Cited by 2,497 · cited 4×
“The TNF-related apoptosis-inducing ligand (TRAIL or Apo2L) is a particularly promising target because it has been shown to selectively induce apoptosis in cancer cells (50, 51).”
BackgroundInfluentialSafety and antitumor activity of recombinant soluble Apo2 ligand
Ashkenazi, A., Pai, R. C., Fong, S., Leung, S., Lawrence, D. A., Marsters, S. A., Blackie, C., Chang, L., McMurtrey, A. E., Hebert, A., et al. (1999) · Journal of Clinical Investigation · doi:10.1172/jci6926 · Cited by 2,213
The Receptor for the Cytotoxic Ligand TRAIL
Pan, G., O'Rourke, K., Chinnaiyan, A. M., Gentz, R., Ebner, R., Ni, J., & Dixit, V. M. (1997) · Science · doi:10.1126/science.276.5309.111 · Cited by 1,767
Osteoprotegerin Is a Receptor for the Cytotoxic Ligand TRAIL
Emery, J. G., McDonnell, P., Burke, M. B., Deen, K. C., Lyn, S., Silverman, C., Dul, E., Appelbaum, E. R., Eichman, C., DiPrinzio, R., et al. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.23.14363 · Cited by 1,184
TNF? and the TNF receptor superfamily: Structure-function relationship(s)
Idriss, H. T., & Naismith, J. H. (2000) · Microscopy Research and Technique · doi:10.1002/1097-0029(20000801)50:3<184::aid-jemt2>3.0.co;2-h · Cited by 1,183
Banner, D. W., D'Arcy, A., Janes, W., Gentz, R., Schoenfeld, H.-J., Broger, C., Loetscher, H., & Lesslauer, W. (1993) · Cell · doi:10.1016/0092-8674(93)90132-a · Cited by 1,104
Molecular Basis of NF-κB Signaling
Napetschnig, J., & Wu, H. (2013) · Annual Review of Biophysics · doi:10.1146/annurev-biophys-083012-130338 · Cited by 933
The molecular architecture of the TNF superfamily
Bodmer, J.-L., Schneider, P., & Tschopp, J. (2002) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(01)01995-8 · Cited by 916
A Domain in TNF Receptors That Mediates Ligand-Independent Receptor Assembly and Signaling
Chan, F. K.-M., Chun, H. J., Zheng, L., Siegel, R. M., Bui, K. L., & Lenardo, M. J. (2000) · Science · doi:10.1126/science.288.5475.2351 · Cited by 856
Chaudhary, P. M., Eby, M., Jasmin, A., Bookwalter, A., Murray, J., & Hood, L. (1997) · Immunity · doi:10.1016/s1074-7613(00)80400-8 · Cited by 711
Fas Preassociation Required for Apoptosis Signaling and Dominant Inhibition by Pathogenic Mutations
Siegel, R. M., Frederiksen, J. K., Zacharias, D. A., Chan, F. K.-M., Johnson, M., Lynch, D., Tsien, R. Y., & Lenardo, M. J. (2000) · Science · doi:10.1126/science.288.5475.2354 · Cited by 662
A novel receptor for Apo2L/TRAIL contains a truncated death domain
Marsters, S. A., Sheridan, J. P., Pitti, R. M., Huang, A., Skubatch, M., Baldwin, D., Yuan, J., Gurney, A., Goddard, A. D., Godowski, P., et al. (1997) · Current Biology · doi:10.1016/s0960-9822(06)00422-2 · Cited by 653
Chen, X., Bäumel, M., Männel, D. N., Howard, O. M. Z., & Oppenheim, J. J. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.1.154 · Cited by 548
The Death Domain Superfamily in Intracellular Signaling of Apoptosis and Inflammation
Park, H. H., Lo, Y.-C., Lin, S.-C., Wang, L., Yang, J. K., & Wu, H. (2007) · Annual Review of Immunology · doi:10.1146/annurev.immunol.25.022106.141656 · Cited by 526
Eck, M. J., & Sprang, S. R. (1990) · PubMed · doi:10.2210/pdb1tnf/pdb · Cited by 507
The Structure of Tumor Necrosis Factor-α at 2.6 Å Resolution
Eck, M. J., & Sprang, S. R. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)71533-0 · Cited by 473
Hales, T. C. (2001) · Discrete & Computational Geometry · doi:10.1007/s004540010071 · Cited by 467
TRAF molecules in cell signaling and in human diseases
Xie, P. (2013) · Journal of Molecular Signaling · doi:10.1186/1750-2187-8-7 · Cited by 466
Herbst, R. S., Eckhardt, S. G., Kurzrock, R., Ebbinghaus, S., O'Dwyer, P. J., Gordon, M. S., Novotny, W., Goldwasser, M. A., Tohnya, T. M., Lum, B. L., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.25.1991 · Cited by 446
Kelley, S. K., Harris, L. A., Xie, D., DeForge, L., Totpal, K., Bussiere, J., & Fox, J. A. (2001) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)29298-3 · Cited by 445
Hymowitz, S. G., Christinger, H. W., Fuh, G., Ultsch, M., O'Connell, M., Kelley, R. F., Ashkenazi, A., & de Vos, A. M. (1999) · Molecular Cell · doi:10.1016/s1097-2765(00)80207-5 · Cited by 435
NMR structure and mutagenesis of the Fas (APO-1/CD95) death domain
Huang, B., Eberstadt, M., Olejniczak, E. T., Meadows, R. P., & Fesik, S. W. (1996) · Nature · doi:10.1038/384638a0 · Cited by 385
The Fas–FADD death domain complex structure unravels signalling by receptor clustering
Scott, F. L., Stec, B., Pop, C., Dobaczewska, M. K., Lee, J. J., Monosov, E., Robinson, H., Salvesen, G. S., Schwarzenbacher, R., & Riedl, S. J. (2009) · Nature · doi:10.1038/nature07606 · Cited by 384
E2 interaction and dimerization in the crystal structure of TRAF6
Yin, Q., Lin, S.-C., Lamothe, B., Lu, M., Lo, Y.-C., Hura, G., Zheng, L., Rich, R. L., Campos, A. D., Myszka, D. G., et al. (2009) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.1605 · Cited by 354
Peppel, K., Crawford, D., & Beutler, B. (1991) · The Journal of experimental medicine · doi:10.1084/jem.174.6.1483 · Cited by 321
Insights into Programmed Cell Death through Structural Biology
Fesik, S. W. (2000) · Cell · doi:10.1016/s0092-8674(00)00119-7 · Cited by 312
Onto better TRAILs for cancer treatment
de Miguel, D., Lemke, J., Anel, A., Walczak, H., & Martinez-Lostao, L. (2016) · Cell Death & Differentiation · doi:10.1038/cdd.2015.174 · Cited by 304
NMR structure of the death domain of the p75 neurotrophin receptor
Liepinsh, E. (1997) · The EMBO Journal · doi:10.1093/emboj/16.16.4999 · Cited by 303
A Unique Zinc-Binding Site Revealed by a High-Resolution X-ray Structure of Homotrimeric Apo2L/TRAIL
Hymowitz, S. G., O'Connell, M. P., Ultsch, M. H., Hurst, A., Totpal, K., Ashkenazi, A., de Vos, A. M., & Kelley, R. F. (2000) · Biochemistry · doi:10.1021/bi992242l · Cited by 261
Jones, E. Y., Mongkolsapaya, J., Grimes, J. M., Chen, N., Xu, X., Stuart, D. I., & Screaton, G. R. (1999) · Nature Structural Biology · doi:10.1038/14935 · Cited by 253
Hexagonal assembly of a restricting TRIM5α protein
Ganser-Pornillos, B. K., Chandrasekaran, V., Pornillos, O., Sodroski, J. G., Sundquist, W. I., & Yeager, M. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1013426108 · Cited by 248
2 å crystal structure of an extracellular fragment of human CD40 ligand
Karpusas, M., Hsu, Y.-M., Wang, J.-H., Thompson, J., Lederman, S., Chess, L., & Thomas, D. (1995) · Structure · doi:10.1016/s0969-2126(01)00239-8 · Cited by 240
Cell death induction by receptors of the TNF family: towards a molecular understanding
Wallach, D., Boldin, M., Varfolomeev, E., Beyaert, R., Vandenabeele, P., & Fiers, W. (1997) · FEBS Letters · doi:10.1016/s0014-5793(97)00553-x · Cited by 233
Clancy, L., Mruk, K., Archer, K., Woelfel, M., Mongkolsapaya, J., Screaton, G., Lenardo, M. J., & Chan, F. K.-M. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0507329102 · Cited by 232
Soria, J.-C., Smit, E., Khayat, D., Besse, B., Yang, X., Hsu, C.-P., Reese, D., Wiezorek, J., & Blackhall, F. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.25.4847 · Cited by 231
Solution of the Structure of the TNF-TNFR2 Complex
Mukai, Y., Nakamura, T., Yoshikawa, M., Yoshioka, Y., Tsunoda, S.-I., Nakagawa, S., Yamagata, Y., & Tsutsumi, Y. (2010) · Science Signaling · doi:10.1126/scisignal.2000954 · Cited by 221
Ganten, T. M., Koschny, R., Sykora, J., Schulze-Bergkamen, H., Büchler, P., Haas, T. L., Schader, M. B., Untergasser, A., Stremmel, W., & Walczak, H. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-2635 · Cited by 217
Zheng, C., Kabaleeswaran, V., Wang, Y., Cheng, G., & Wu, H. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.03.009 · Cited by 205
Structural determinants of TRIM protein function
Esposito, D., Koliopoulos, M. G., & Rittinger, K. (2017) · Biochemical Society Transactions · doi:10.1042/bst20160325 · Cited by 198
Crystal Structure of sTALL-1 Reveals a Virus-like Assembly of TNF Family Ligands
Liu, Y., Xu, L., Opalka, N., Kappler, J., Shu, H.-B., & Zhang, G. (2002) · Cell · doi:10.1016/s0092-8674(02)00631-1 · Cited by 195
Crystal structure of the TRANCE/RANKL cytokine reveals determinants of receptor-ligand specificity
Lam, J., Nelson, C. A., Ross, F. P., Teitelbaum, S. L., & Fremont, D. H. (2001) · Journal of Clinical Investigation · doi:10.1172/jci13890 · Cited by 194
Kindler, H. L., Richards, D. A., Garbo, L. E., Garon, E. B., Stephenson, J. J., Rocha-Lima, C. M., Safran, H., Chan, D., Kocs, D. M., Galimi, F., et al. (2012) · Annals of Oncology · doi:10.1093/annonc/mds142 · Cited by 193
Structural Basis and Functional Role of Intramembrane Trimerization of the Fas/CD95 Death Receptor
Fu, Q., Fu, T.-M., Cruz, A. C., Sengupta, P., Thomas, S. K., Wang, S., Siegel, R. M., Wu, H., & Chou, J. J. (2016) · Molecular Cell · doi:10.1016/j.molcel.2016.01.009 · Cited by 191 · cited 1×
“Ligand binding results in the trimerization of the receptor transmembrane domain (94).”
BackgroundCrystallographic Evidence for Dimerization of Unliganded Tumor Necrosis Factor Receptor
Naismith, J. H., Devine, T. Q., Brandhuber, B. J., & Sprang, S. R. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.22.13303 · Cited by 190
The structure of human lymphotoxin (tumor necrosis factor-beta) at 1.9-A resolution.
Eck, M. J., Ultsch, M., Rinderknecht, E., de Vos, A. M., & Sprang, S. R. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)45849-8 · Cited by 187
Nguyen, D. X., & Ehrenstein, M. R. (2016) · Journal of Experimental Medicine · doi:10.1084/jem.20151255 · Cited by 184
Papoff, G., Hausler, P., Eramo, A., Pagano, M. G., Di Leve, G., Signore, A., & Ruberti, G. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.53.38241 · Cited by 183
Cysteine 230 Is Essential for the Structure and Activity of the Cytotoxic Ligand TRAIL
Bodmer, J.-L., Meier, P. F., Tschopp, J., & Schneider, P. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m909721199 · Cited by 182
Torrey, H., Butterworth, J., Mera, T., Okubo, Y., Wang, L., Baum, D., Defusco, A., Plager, S., Warden, S., Huang, D., et al. (2017) · Science Signaling · doi:10.1126/scisignal.aaf8608 · Cited by 182
Self-citationHomogeneous Expansion of Human T-Regulatory Cells Via Tumor Necrosis Factor Receptor 2
Okubo, Y., Mera, T., Wang, L., & Faustman, D. L. (2013) · Scientific Reports · doi:10.1038/srep03153 · Cited by 170
Self-citationGraves, J. D., Kordich, J. J., Huang, T.-H., Piasecki, J., Bush, T. L., Sullivan, T., Foltz, I. N., Chang, W., Douangpanya, H., Dang, T., et al. (2014) · Cancer Cell · doi:10.1016/j.ccr.2014.04.028 · Cited by 169
Structures of APRIL-Receptor Complexes
Hymowitz, S. G., Patel, D. R., Wallweber, H. J. A., Runyon, S., Yan, M., Yin, J., Shriver, S. K., Gordon, N. C., Pan, B., Skelton, N. J., et al. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m411714200 · Cited by 166
TNF Receptor 2 and Disease: Autoimmunity and Regenerative Medicine
Faustman, D. L., & Davis, M. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00478 · Cited by 160
Self-citation2.8 Å Resolution Crystal Structure of Human TRAIL, a Cytokine with Selective Antitumor Activity
Cha, S.-S., Kim, M.-S., Choi, Y. H., Sung, B.-J., Shin, N. K., Shin, H.-C., Sung, Y. C., & Oh, B.-H. (1999) · Immunity · doi:10.1016/s1074-7613(00)80100-4 · Cited by 158
Structural and Functional Insights of RANKL–RANK Interaction and Signaling
Liu, C., Walter, T. S., Huang, P., Zhang, S., Zhu, X., Wu, Y., Wedderburn, L. R., Tang, P., Owens, R. J., Stuart, D. I., et al. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0904033 · Cited by 153
The Crystal Structure of the Costimulatory OX40-OX40L Complex
Compaan, D. M., & Hymowitz, S. G. (2006) · Structure · doi:10.1016/j.str.2006.06.015 · Cited by 150
Cha, S., Sung, B., Kim, Y., Song, Y.-L., Kim, H.-J., Kim, S., Lee, M., & Oh, B. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m004414200 · Cited by 145
Crystal structure of extracellular human BAFF, a TNF family member that stimulates B lymphocytes
Karpusas, M., Cachero, T. G., Qian, F., Boriack-Sjodin, A., Mullen, C., Strauch, K., Hsu, Y., & Kalled, S. L. (2002) · Journal of Molecular Biology · doi:10.1006/jmbi.2001.5296 · Cited by 136
The Solution Structure of FADD Death Domain
Jeong, E.-J., Bang, S., Lee, T. H., Park, Y. I., Sim, W. S., & Kim, K. S. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.23.16337 · Cited by 133
Berg, D., Lehne, M., Müller, N., Siegmund, D., Münkel, S., Sebald, W., Pfizenmaier, K., & Wajant, H. (2007) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4402213 · Cited by 130
Ligand–receptor binding revealed by the TNF family member TALL-1
Liu, Y., Hong, X., Kappler, J. W., Jiang, L., Zhang, R., Xu, L., Pan, C., Martin, W. E., Murphy, R. C., Shu, H., et al. (2003) · Nature · doi:10.1038/nature01543 · Cited by 129
Regulation of TNFRSF and innate immune signalling complexes by TRAFs and cIAPs
Silke, J., & Brink, R. A. (2009) · Cell Death and Differentiation · doi:10.1038/cdd.2009.114 · Cited by 125
Oligomeric tumour necrosis factor α slowly converts into inactive forms at bioactive levels
Corti, A., Fassina, G., Marcucci, F., Barbanti, E., & Cassani, G. (1992) · Biochemical Journal · doi:10.1042/bj2840905 · Cited by 123
Structural Basis for the Lack of E2 Interaction in the RING Domain of TRAF2
Yin, Q., Lamothe, B., Darnay, B. G., & Wu, H. (2009) · Biochemistry · doi:10.1021/bi901462e · Cited by 119
Goldstone, D. C., Walker, P. A., Calder, L. J., Coombs, P. J., Kirkpatrick, J., Ball, N. J., Hilditch, L., Yap, M. W., Rosenthal, P. B., Stoye, J. P., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1402448111 · Cited by 113
Crystal Structure of Human RANKL Complexed with Its Decoy Receptor Osteoprotegerin
Luan, X., Lu, Q., Jiang, Y., Zhang, S., Wang, Q., Yuan, H., Zhao, W., Wang, J., & Wang, X. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1103387 · Cited by 112
Berglund, H., Olerenshaw, D., Sankar, A., Federwisch, M., McDonald, N. Q., & Driscoll, P. C. (2000) · Journal of Molecular Biology · doi:10.1006/jmbi.2000.4011 · Cited by 111
The Crystal Structures of EDA-A1 and EDA-A2
Hymowitz, S. G., Compaan, D. M., Yan, M., Wallweber, H. J. A., Dixit, V. M., Starovasnik, M. A., & de Vos, A. M. (2003) · Structure · doi:10.1016/j.str.2003.11.009 · Cited by 102
An, H., Kim, Y., Song, D. H., Park, B. S., Kim, H. M., Lee, J. D., Paik, S., Lee, H., & Lee, H. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.208215 · Cited by 99
Targeting of the Tumor Necrosis Factor Receptor Superfamily for Cancer Immunotherapy
Bremer, E. (2013) · ISRN Oncology · doi:10.1155/2013/371854 · Cited by 95
Asymmetric Recruitment of cIAPs by TRAF2
Mace, P. D., Smits, C., Vaux, D. L., Silke, J., & Day, C. L. (2010) · Journal of Molecular Biology · doi:10.1016/j.jmb.2010.04.055 · Cited by 89
Crystal structure of the BAFF–BAFF-R complex and its implications for receptor activation
Kim, H. M., Yu, K. S., Lee, M. E., Shin, D. R., Kim, Y. S., Paik, S., Yoo, O. J., Lee, H., & Lee, J. (2003) · Nature Structural & Molecular Biology · doi:10.1038/nsb925 · Cited by 88
Schneider, B., Münkel, S., Krippner‐Heidenreich, A., Grunwald, I., Wels, W. S., Wajant, H., Pfizenmaier, K., & Gerspach, J. (2010) · Cell Death and Disease · doi:10.1038/cddis.2010.45 · Cited by 82
Paz-Ares, L. G., Bálint, B., Boer, R. H. D., van Meerbeeck, J. P., Wierzbicki, R. F., SOUZA, P. D., Galimi, F., Haddad, V., Sabin, T., Hei, Y.-J., et al. (2013) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e31827ce554 · Cited by 81
TRAIL-R2-specific antibodies and recombinant TRAIL can synergise to kill cancer cells
Tuthill, M. H., Montinaro, A., Zinngrebe, J., Prieske, K., Dráber, P., Prieske, S., Newsom-Davis, T. E., von Karstedt, S., Graves, J. D., & Walczak, H. (2014) · Oncogene · doi:10.1038/onc.2014.156 · Cited by 81
Chattopadhyay, K., Ramagopal, U. A., Brenowitz, M. D., Nathenson, S. G., & Almo, S. C. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0710529105 · Cited by 70
Decoy Strategies: The Structure of TL1A:DcR3 Complex
Zhan, C., Patskovsky, Y., Yan, Q., Li, Z., Ramagopal, U. A., Cheng, H., Brenowitz, M. D., Hui, X., Nathenson, S. G., & Almo, S. C. (2011) · Structure · doi:10.1016/j.str.2010.12.004 · Cited by 69
The Crystal Structure of A Proliferation-inducing Ligand, APRIL
Wallweber, H. J. A., Compaan, D. M., Starovasnik, M. A., & Hymowitz, S. G. (2004) · Journal of Molecular Biology · doi:10.1016/j.jmb.2004.08.040 · Cited by 68
Chattopadhyay, K., Ramagopal, U. A., Mukhopadhaya, A., Malashkevich, V. N., DiLorenzo, T. P., Brenowitz, M. D., Nathenson, S. G., & Almo, S. C. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0709264104 · Cited by 65
Richter, C. E., Messerschmidt, S. K. E., Holeiter, G., Tepperink, J., Osswald, S., Zappe, A., Branschädel, M., Boschert, V., Mann, D. A., Scheurich, P., et al. (2012) · Molecular and Cellular Biology · doi:10.1128/mcb.06458-11 · Cited by 65
Solution structure of the tumor necrosis factor receptor-1 death domain
Sukits, S. F., Lin, L.-L., Hsu, S., Malakian, K., Powers, R., & Xu, G.-Y. (2001) · Journal of Molecular Biology · doi:10.1006/jmbi.2001.4790 · Cited by 51
Engineering a leucine zipper-TRAIL homotrimer with improved cytotoxicity in tumor cells
Rozanov, D. V., Savinov, A. Y., Golubkov, V. S., Rozanova, O. L., Postnova, T. I., Sergienko, E. A., Vasile, S., Aleshin, A. E., Rega, M. F., Pellecchia, M., et al. (2009) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-09-0202 · Cited by 48
Biochemical and Structural Characterization of the Human TL1A Ectodomain ,
Zhan, C., Yan, Q., Patskovsky, Y., Li, Z., Toro, R., Meyer, A., Cheng, H., Brenowitz, M. D., Nathenson, S. G., & Almo, S. C. (2009) · Biochemistry · doi:10.1021/bi900031w · Cited by 40
Dimerization of LTβR by LTα 1 β 2 is necessary and sufficient for signal transduction
Sudhamsu, J., Yin, J., Chiang, E. Y., Starovasnik, M. A., Grogan, J. L., & Hymowitz, S. G. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1310838110 · Cited by 39
Liu, W., Zhan, C., Cheng, H., Kumar, P. R., Bonanno, J. B., Nathenson, S. G., & Almo, S. C. (2014) · Structure · doi:10.1016/j.str.2014.06.013 · Cited by 38
TNFR-Associated Factor-2 (TRAF2): Not Only a Trimer
Ceccarelli, A., Venere, A. D., Nicolai, E., Luca, A. D., Minicozzi, V., Rosato, N., Caccuri, A. M., & Mei, G. (2015) · Biochemistry · doi:10.1021/acs.biochem.5b00674 · Cited by 21
Patterns and clusters within the PSM column in , 1992?2004
McEntyre, J., & Gibson, T. J. (2004) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2004.10.006 · Cited by 18
Ban, L., Kühtreiber, W. M., Butterworth, J., Okubo, Y., Vanamee, É. S., & Faustman, D. L. (2015) · Molecular and Cellular Therapies · doi:10.1186/s40591-015-0044-4 · Cited by 17
Self-citation
Cited by
Antibody Structure and Function: The Basis for Engineering Therapeutics
Chiu, M. L., Goulet, D. R., Teplyakov, A., & Gilliland, G. L. (2019) · Antibodies · doi:10.3390/antib8040055 · Cited by 638
The TNF Family of Ligands and Receptors: Communication Modules in the Immune System and Beyond
Dostert, C., Grusdat, M., Letellier, E., & Brenner, D. (2019) · Physiological Reviews · doi:10.1152/physrev.00045.2017 · Cited by 498
Kinase inhibition in autoimmunity and inflammation
Zarrin, A. A., Bao, K., Lupardus, P., & Vucic, D. (2021) · Nature Reviews Drug Discovery · doi:10.1038/s41573-020-0082-8 · Cited by 431
Unleashing endogenous TNF-alpha as a cancer immunotherapeutic
Josephs, S. F., Ichim, T. E., Prince, S. M., Kesari, S., Marincola, F. M., Escobedo, A. R., & Jafri, A. (2018) · Journal of Translational Medicine · doi:10.1186/s12967-018-1611-7 · Cited by 257
Tumour Necrosis Factor Alpha in Intestinal Homeostasis and Gut Related Diseases
Ruder, B., Atreya, R., & Becker, C. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20081887 · Cited by 228
Metadata
- Authors
- Vanamee, É. S., & Faustman, D. L.
- Venue
- Science Signaling
- Published
- 2018-01-02
- Volume
- 11
- Issue
- 511
- ISSN
- 1937-9145 (ISSN-L)
- 1945-0877
- OpenAlex
- W2782231020
- Cited by
- 280
- References
- 90
- FWCI
- 9.18
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.